SCHEMBL28066873

SCHEMBL28066873

CC(C)OC(=O)Nc1cc(Cl)nc(Cl)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.48
ALOX15 P16050 1/20 0.48
ATF1 P18846 1/20 0.43
NFKB1 P19838 1/20 0.43
TUBB4A P04350 2/20 0.43
TUBB P07437 2/20 0.43
TUBA3C P0DPH7 2/20 0.43
TUBA1B P68363 2/20 0.43
TUBA4A P68366 2/20 0.43
TUBB4B P68371 2/20 0.43
TUBB3 Q13509 2/20 0.43
TUBB2A Q13885 2/20 0.43
TUBB8 Q3ZCM7 2/20 0.43
TUBA3E Q6PEY2 2/20 0.43
TUBA1A Q71U36 2/20 0.43
TUBA1C Q9BQE3 2/20 0.43
TUBB6 Q9BUF5 2/20 0.43
TUBB2B Q9BVA1 2/20 0.43
TUBB1 Q9H4B7 2/20 0.43
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17617989 0.78 IDH1 (0.49) HPGDALOX15TUBB4ATUBBTUBA3C
SCHEMBL73113 0.78 HPGD (0.59) HPGDALOX15TUBB4ATUBBTUBA3C
SCHEMBL1489997 0.78 ATF1 (0.48) ATF1NFKB1KDM4ENPC1RAB9A
SCHEMBL23050263 0.76 BCHE (0.41) HPGDATF1NFKB1CYP1A2CYP2C9
SCHEMBL16372124 0.75 ATF1 (0.49) HPGDALOX15ATF1NFKB1KDM4E
SCHEMBL3365555 0.73 HPGD (0.47) HPGDALOX15TUBB4ATUBBTUBA3C
SCHEMBL27500457 0.71 CYP1A2 (0.51) HPGDALOX15NFKB1TUBB4ATUBB
SCHEMBL11841419 0.70 PTK2 (0.61) HPGDALOX15NFKB1KDM4EALDH1A1
SCHEMBL1748325 0.70 GAA (0.48) ATF1NFKB1ALDH1A1ESR1
SCHEMBL9358296 0.69 HPGD (0.71) HPGDALOX15KDM4EALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105593215-A 2, 4-or 4, 6-diaminopyrimidine compounds as IDH2 mutant inhibitors for the treatment of cancer AGIOS PHARMACEUTICALS INC 2016-05-18 CN disclosed